TSO3 (TOS) Price Target Lowered to C$1.75 at Royal Bank of Canada
TOS has been the topic of several other research reports. National Bank Financial downgraded shares of TSO3 from an outperform rating to a sector perform rating and dropped their price objective for the stock from C$5.50 to C$2.25 in a report on Monday, January 29th. Desjardins downgraded shares of TSO3 from a buy rating to a hold rating in a report on Friday, January 26th. Canaccord Genuity downgraded shares of TSO3 from a buy rating to a speculative buy rating and dropped their price objective for the stock from C$4.25 to C$2.75 in a report on Friday, January 26th. Finally, Scotiabank dropped their price objective on shares of TSO3 from C$4.50 to C$2.75 and set an outperform rating on the stock in a report on Tuesday, January 30th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The company presently has an average rating of Hold and an average price target of C$2.70.
TSO3 (TSE TOS) opened at C$1.12 on Tuesday. TSO3 has a twelve month low of C$1.05 and a twelve month high of C$3.32. The stock has a market cap of $107.71, a PE ratio of -10.18 and a beta of 1.11.
TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.
Receive News & Ratings for TSO3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 and related companies with MarketBeat.com's FREE daily email newsletter.